Related Experiment Video
Updated: May 11, 2026

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
Impaired coronary tissue plasminogen activator release is associated with coronary atherosclerosis and cigarette
D E Newby1, A L McLeod, N G Uren
1Departments of Cardiology, University of Edinburgh, Royal Infirmary, United Kingdom. d.e.newby@ed.ac.uk
Insights
Coronary artery plaque and smoking impair the heart's ability to release tissue plasminogen activator (tPA). This reduced fibrinolytic capacity is linked to endothelial dysfunction and may affect heart attack treatment in smokers.
Area of Science:
- Cardiology
- Vascular Biology
- Thrombosis
Background:
- Atherosclerosis and smoking are known risk factors for cardiovascular disease.
- The impact of coronary atheroma and smoking on stimulated tissue plasminogen activator (tPA) release is not fully understood.
Purpose of the Study:
- To investigate the influence of proximal coronary artery atheroma and smoking on the stimulated release of tPA from the heart.
- To explore the relationship between plaque burden, smoking, and local fibrinolytic capacity.
Main Methods:
- 25 patients underwent coronary angiography, with proximal LAD plaque volume assessed by IVUS.
- Fibrinolytic responses to substance P and sodium nitroprusside were measured via intracoronary infusion and blood sampling.
- Coronary blood flow and tPA antigen/activity were analyzed.
Main Results:
- Increased plaque burden in the LAD was inversely correlated with active tPA release (r=-0.61, P=0.003).
- Current and ex-smokers showed significantly impaired coronary release of active tPA compared to non-smokers (P<0.05).
- Substance P infusion increased tPA release, while sodium nitroprusside increased blood flow.
Conclusions:
- Coronary atheromatous plaque burden and smoking habit are associated with reduced local fibrinolytic capacity.
- Findings suggest a link between endogenous fibrinolysis, endothelial dysfunction, and atherothrombosis.
- These factors may explain variations in thrombolytic therapy efficacy for myocardial infarction in smokers.
Background:
The aim of the study was to establish the influence of proximal coronary artery atheroma and smoking habit on the stimulated release of tissue plasminogen activator (tPA) from the heart.
Methods And Results:
After diagnostic coronary angiography in 25 patients, the left anterior descending coronary artery (LAD) was instrumented, and the proximal LAD plaque volume was determined by use of intravascular ultrasound (IVUS). Blood flow and fibrinolytic responses to selective LAD infusion of saline, substance P (10 to 40 pmol/min; endothelium-dependent), and sodium nitroprusside (5 to 20 microgram/min; endothelium-independent) were measured by intracoronary IVUS and Doppler, combined with arterial and coronary sinus blood sampling. Mean plaque burden was 5.5+/-0.8 mm(3)/mm vessel (range 0.6 to 13.7 mm(3)/mm vessel). LAD blood flow increased with both substance P and sodium nitroprusside (P<0.001), although coronary sinus plasma tPA antigen and activity concentrations increased only during substance P infusion (P<0.006 for both). There was a strong inverse correlation between the LAD plaque burden and release of active tPA (r=-0.61, P=0.003). Cigarette smoking was associated with impaired coronary release of active tPA (current smokers, 31+/-23 IU/min; ex-smokers, 50+/-33 IU/min; nonsmokers 202+/-73 IU/min; P<0.05).
Conclusions:
We found that both the coronary atheromatous plaque burden and smoking habit are associated with a reduced acute local fibrinolytic capacity of the heart. These important findings provide evidence of a direct link between endogenous fibrinolysis, endothelial dysfunction, and atherothrombosis in the coronary circulation and may explain the greater efficacy of thrombolytic therapy for myocardial infarction in cigarette smokers.
More Related Videos
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Atherosclerosis I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Peripheral Artery Disease I: Introduction

